BioGlyph

Curated by Signal

Provider of software tools to accelerate and improve the discovery and development of Biologics

Overview

Provider of software tools to accelerate and improve the discovery and development of Biologics. It specializing in Multispecific Antibody research and development with a focus on innovative therapeutic applications. It leverages advanced technologies to design and produce highly specific antibodies that address complex biological challenges.

Key facts

Founded: 2023
Headquarters: Berkeley, United States
Stage: Sign up to view
Industry: Health Technology

Business model

7 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

BuildMySOP
Provider of software solutions for compliance and operational efficiency in the cannabis industry
Health TechnologyAlbuquerque, United States
PathVision.ai
Provider of AI-based diagnostic software for pathologists
Health TechnologyUnited States
Altra Medical
Online medical training supplies for healthcare professionals
Health TechnologyPinellas Park, United States

About BioGlyph

What does BioGlyph do?

Provider of software tools to accelerate and improve the discovery and development of Biologics.

Where is BioGlyph headquartered?

BioGlyph is headquartered in Berkeley, United States.

When was BioGlyph founded?

BioGlyph was founded in 2023.

Which sector is BioGlyph in?

BioGlyph operates in Health Technology.

Who are BioGlyph's competitors?

Companies similar to BioGlyph include BuildMySOP, PathVision.ai, and Altra Medical.